Integrated Smoking Cessation and Mood Management for ACS Patients

Withdrawn before enrolling · Not applicable

Conditions studied: Acute Coronary Syndrome, Tobacco Use

In brief

Quitting smoking following acute coronary syndrome can reduce mortality up to 50%. However, depression and smoking are highly co-morbid and depressed mood may interfere with cessation and independently predicts mortality. Thus, a single, integrated treatment for both smoking and depression could be highly effective in reducing post-acute coronary syndrome mortality. Behavioral Activation (BA) is a well established treatment for depression and has recently shown promise as a treatment for smoking cessation. The investigators systematically developed an intervention integrating gold standard smoking cessation counseling with existing BA based mood management techniques for post-ACS smokers; Behavioral Activation Treatment for Cardiac Smokers (BAT-CS). Objective: For this R56 the investigators will conduct a vanguard trial to pilot all methods, materials, and systems for the later fully powered BAT-CS vs. attention control trial. The investigators will enroll up to 36 smokers with ACS and randomize them to 12 weeks of BAT-CS or an attention control (Health and Wellness Education). Both groups will be offered the nicotine patch if medically safe.

Key facts

Study ID

NCT03029923

Run by

The Miriam Hospital

People needed

0

Starts

2017-02-01

Expected to finish

2017-12-01

Last updated by the study team

2017-08-29

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• hospital inpatients with an ACS diagnosis documented in medical record,
• smoked 1 or more cigarettes per day before being hospitalized,
• age of 18-75,
• English fluency,
• lives within a 1 hour drive of the admitting hospital and has no plans to move away from the area for 1 year,
• willing to consider quitting smoking at discharge,
• has telephone, and
• willing to consent to all study procedures.

You may not qualify if…

• limited mental competency (i.e., Mini Mental Status Exam score ≤ 23);
• presence of severe mental illness that would interfere with participation (e.g., schizophrenia) or suicidality;
• expected discharge to hospice; and
• currently attending counseling for depression or smoking cessation.

Where it is running

• The Miriam Hospital — Providence, Rhode Island, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.